Marie José Kersten Selected Research

Marie José Kersten Research Topics

Disease

26	Neoplasms (Cancer) 04/2024 - 01/2003
18	B-Cell Lymphoma (Lymphoma, B Cell) 04/2024 - 01/2020
17	Lymphoma (Lymphomas) 02/2024 - 01/2003
17	Multiple Myeloma 05/2023 - 04/2008
12	Hodgkin Disease (Hodgkin's Disease) 03/2024 - 12/2009
12	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2024 - 01/2014
10	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2024 - 04/2011
9	Waldenstrom Macroglobulinemia (Macroglobulinemia) 03/2024 - 03/2016
8	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2023 - 01/2003
5	Cytokine Release Syndrome 01/2024 - 01/2020
5	Infections 12/2022 - 09/2008
5	Fatigue 09/2021 - 12/2010
4	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 03/2024 - 04/2018
4	Disease Progression 02/2024 - 02/2020
4	Paraproteinemias (Monoclonal Gammopathy) 01/2023 - 01/2017
4	Hematologic Neoplasms (Hematological Malignancy) 12/2022 - 12/2010
3	Peripheral Nervous System Diseases (PNS Diseases) 07/2022 - 01/2017
3	Fever (Fevers) 01/2021 - 09/2012
2	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 07/2023 - 01/2022
2	T-Cell Lymphoma (Lymphoma, T Cell) 11/2022 - 01/2022
2	Monoclonal Gammopathy of Undetermined Significance 07/2022 - 01/2022
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 01/2018
2	Leukemia 01/2019 - 07/2015
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2018 - 01/2016
2	Neutropenia 04/2016 - 09/2012
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2013 - 06/2010
1	Breast Neoplasms (Breast Cancer) 02/2024
1	Residual Neoplasm 01/2023
1	Bursitis (Adhesive Capsulitis) 12/2022
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2022
1	Schnitzler Syndrome 01/2022
1	Cryoglobulinemia 01/2022
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2022
1	Immunoglobulin Light-chain Amyloidosis 01/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Polyneuropathies (Polyneuropathy) 01/2022
1	Communicable Diseases (Infectious Diseases) 12/2021
1	COVID-19 12/2021
1	Ototoxicity 01/2021

Drug/Important Bio-Agent (IBA)

15	Chimeric Antigen ReceptorsIBA 08/2023 - 01/2020
11	axicabtagene ciloleucelIBA 04/2024 - 01/2020
10	Rituximab (Mabthera)FDA Link 11/2022 - 04/2011
8	tisagenlecleucelIBA 01/2024 - 01/2018
6	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2024 - 01/2017
6	Biomarkers (Surrogate Marker)IBA 07/2022 - 01/2014
5	ibrutinibIBA 03/2024 - 03/2016
5	Immunoglobulin M (IgM)IBA 01/2023 - 01/2017
5	Vincristine (Oncovin)FDA LinkGeneric 11/2022 - 01/2017
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2022 - 01/2017
5	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 12/2017
5	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 06/2010
4	Brentuximab VedotinIBA 03/2024 - 01/2019
4	tocilizumab (atlizumab)FDA Link 01/2024 - 11/2020
4	Lenalidomide (CC 5013)FDA Link 12/2020 - 04/2010
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2024 - 01/2021
3	EnzymesIBA 01/2023 - 01/2019
3	Prednisone (Sone)FDA LinkGeneric 11/2022 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2021
3	Imatinib Mesylate (Gleevec)FDA Link 01/2019 - 06/2010
2	IntegrinsIBA 03/2024 - 03/2016
2	acalabrutinibIBA 03/2024 - 02/2020
2	Agammaglobulinaemia Tyrosine KinaseIBA 03/2024 - 02/2020
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2023 - 01/2022
2	daratumumabIBA 05/2023 - 12/2021
2	brexucabtagene autoleucelIBA 01/2023 - 01/2022
2	Etoposide (VP 16)FDA LinkGeneric 11/2022 - 01/2022
2	ParaproteinsIBA 07/2022 - 01/2022
2	Proteasome InhibitorsIBA 01/2022 - 10/2018
2	ChemokinesIBA 12/2021 - 04/2008
2	Prednisolone (Predate)FDA LinkGeneric 10/2021 - 12/2020
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2019
2	Thalidomide (Thalomid)FDA Link 08/2020 - 10/2018
2	CateninsIBA 01/2018 - 01/2012
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2016 - 09/2012
2	Monoclonal AntibodiesIBA 06/2011 - 04/2011
1	Glucose (Dextrose)FDA LinkGeneric 04/2024
1	Indicators and Reagents (Reagents)IBA 04/2024
1	AutoantibodiesIBA 07/2023
1	Complement System Proteins (Complement)IBA 07/2023
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2023
1	PlatinumIBA 01/2023
1	Vitamin D FDA LinkGeneric 12/2022
1	posaconazole FDA Link 12/2022
1	Myelin-Associated GlycoproteinIBA 07/2022
1	ixazomibIBA 01/2022
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2021
1	Heparitin Sulfate (Heparan Sulfate)IBA 12/2021
1	Chemokine CXCL12IBA 12/2021
1	Biosimilar PharmaceuticalsIBA 10/2021

Therapy/Procedure

28	Therapeutics 02/2024 - 06/2010
15	Drug Therapy (Chemotherapy) 03/2024 - 12/2010
14	Stem Cell Transplantation 03/2024 - 12/2010
3	Salvage Therapy 12/2021 - 01/2019
3	Transplantation 12/2021 - 12/2011
2	Aftercare (After-Treatment) 12/2022 - 12/2009
2	Immunotherapy 12/2022 - 08/2022
2	Remission Induction 08/2020 - 12/2011
2	Diet Therapy (Therapy, Diet) 04/2016 - 09/2012
1	Radiotherapy 02/2024
1	Phototherapy (Light Therapy) 09/2021